Cargando…
Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
Small‐cell lung cancer (SCLC) can be subgrouped into common ‘pure’ and rare ‘combined’ SCLC (c‐SCLC). c‐SCLC features a mixed tumor histology of both SCLC and non–small‐cell lung cancer (NSCLC). We performed targeted exome sequencing on 90 patients with SCLC, including two with c‐SCLC, and discovere...
Autores principales: | He, Tian, Wildey, Gary, McColl, Karen, Savadelis, Alyssa, Spainhower, Kyle, McColl, Cassidy, Kresak, Adam, Tan, Aik Choon, Yang, Michael, Abbas, Ata, Dowlati, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782087/ https://www.ncbi.nlm.nih.gov/pubmed/33084222 http://dx.doi.org/10.1002/1878-0261.12829 |
Ejemplares similares
-
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
por: Abbas, Rime, et al.
Publicado: (2015) -
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
por: McColl, Karen, et al.
Publicado: (2017) -
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma
por: He, Tian, et al.
Publicado: (2018) -
Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263
por: Greenberg, E F, et al.
Publicado: (2015) -
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016)